Study of New Swiss Guidelines to Reduce Antibiotic Use for Respiratory Infections in Primary Care
Led by Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland · Updated on 2026-06-24
200
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether applying new Swiss national guidelines for acute respiratory infections ARI can help lower antibiotic prescriptions in primary care. The study focuses on reducing unnecessary antibiotic use, especially for viral infections where antibiotics are ineffective, to combat antibiotic resistance. It is a hybrid effectiveness-implementation trial conducted in French- and Italian-speaking regions of Switzerland involving family doctors in quality circles and walk-in clinics.
The study compares two groups an intervention group receiving educational materials and training sessions about the new guidelines, including targeted use of point-of-care C-reactive protein CRP testing and shared decision-making with patients, and a control group that continues usual care and receives the materials later. The intervention is delivered through quality circle moderators and clinic directors during sessions in autumn 2025, with follow-up training offered to controls in summer 2026.
Participants in the study are family doctors and clinics who provide primary care. Data is collected anonymously from health insurance billing records to monitor antibiotic prescribing and diagnostic test use over a six-month influenza-like illness season and up to 12 months. Doctors complete brief online surveys twice yearly and may join optional interviews or group discussions. The study tracks guideline adoption, acceptability, and implementation barriers while ensuring data confidentiality and voluntary participation.
CONDITIONS
Brief Title
Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic Prescribing in Swiss Primary Care
Research Team
J
Jelena Dunaiceva, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Lead Sponsor
University of Zurich, Institute for Implementation Science in Health care
Collaborating Sponsor
Who Can Participate
All Ages
All Genders
Eligibility Criteria
You may qualify if you...
Willing to participate in a study mainly conducted in French
Agreeing to participate in evaluation surveys
For walk-in clinics: offers general practice/primary care consultations including emergencies
Walk-in clinics include at least five physicians
Walk-in clinics have admission to practice charged to Swiss compulsory health insurance
Walk-in clinics plan to be active in April 2026
Located in Vaud, Geneva, Valais, Fribourg, Jura, Neuchatel, Bern, or Ticino
Serving mainly adult patients
Registered primary care physicians or specialists in general internal medicine
Practicing in one of the specified cantons
Participating in a QC or in an outpatient clinic included in the study
Physicians willing to participate in French-language study and evaluation surveys
Physicians in clinics have clinical activity as primary care physician or supervise post-graduate physicians
You will not qualify if you...
Quality circles without any physician included in the study
Physicians planning to retire before April 2026
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Implementation of Guidelines
Duration - From autumn 2025 to summer 2026
Quality circles and walk-in clinics in the intervention group receive training and educational materials on the new acute respiratory infection guidelines focused on targeted CRP testing and shared decision-making. Control groups continue usual care and receive the materials later.
Sessions and materials distributed during this period
Data Collection and Follow-up
Duration - Up to 12 months following implementation
Researchers collect de-identified health insurance billing data to monitor antibiotic prescribing and diagnostic test use, and doctors complete online surveys twice a year. Optional interviews or group discussions may occur after the winter season.
Twice yearly surveys and possible interviews
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Similar Trials
Evaluating Abbott ID NOW Rapid Molecular Testing Compared to Standard Laboratory Diagnosis
for Influenza in Long-Term Care Facility Residents in Taiwan
A Cluster-Randomized Controlled Trial
Study of New Swiss Guidelines to Reduce Antibiotic Use for Respiratory Infections in Primary Care
Observational Study Characterizing Acute Respiratory Infections in Emergency and Acute Hospital Care Settings Across Europe
The Fever Clinic Acute Respiratory Cohort Study
Tracking Symptoms, Tests, and Long-Term Outcomes of Respiratory Infections in Adults
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Systematic method for developing tailored strategies for implementing point-of-care procalcitonin testing to guide antibiotic prescribing in Swiss primary care: a protocol for a mixed-methods participatory approach.
Aline Wolfensberger, Sophie Cl Gendolla, Jelena Dunaiceva...